Proethos Fond vs UBS Lux Equity Fund Biotech USD

Proethos Fond vs UBS Lux Equity Fund Biotech USD

1. Proethos Fond

  • Security

    Proethos Fond

  • Fee

    0.65%

  • ISIN

    SE0010547778

  • Holdings

    9

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 11 holdings in Proethos Fond, where the largest holding is Storebrand Grön Obligation A SEK (9.14), followed by Shimano (5.63) and Vestas (5.47). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in Proethos Fond and UBS Lux Equity Fund Biotech USD.

Proethos Fond UBS Lux Equity Fund Biotech USD
1. Storebrand Grön Obligation A SEK
Sweden
9.14 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Shimano ADR
Japan
5.63 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. Vestas Wind Systems A/S
Denmark
5.47 %
3. Moderna Inc
9.21 %
4. Central Japan Railway Co
Japan
4.98 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. NIBE Industrier B
Sweden
4.69 %
5. AbbVie Inc
USA
5.53 %
6. Nordex SE
Germany
4.66 %
6. Gilead Sciences Inc
USA
4.66 %
7. Ormat Technologies Inc
USA
4.46 %
7. Amgen Inc
4.3 %
8. First Solar Inc
USA
4.26 %
8. BioNTech SE
4.13 %
9. Enphase Energy Inc
USA
1.72 %
9. Karuna Therapeutics Inc
3.75 %
- 10. Royalty Pharma Plc
3.37 %

The list of fund holdings was last updated on June 6, 2025.